{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:06:45Z","timestamp":1781021205823,"version":"3.54.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council (NHMRC)","doi-asserted-by":"publisher","award":["1073858"],"award-info":[{"award-number":["1073858"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council (NHMRC)","doi-asserted-by":"publisher","award":["1041472"],"award-info":[{"award-number":["1041472"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council (NHMRC)","doi-asserted-by":"publisher","award":["1045318"],"award-info":[{"award-number":["1045318"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.drugalcdep.2014.05.018","type":"journal-article","created":{"date-parts":[[2014,6,2]],"date-time":"2014-06-02T19:59:53Z","timestamp":1401739193000},"page":"46-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["A latent class analysis of self-reported clinical indicators of psychosocial stability and adherence among opioid substitution therapy patients: Do stable patients receive more unsupervised doses?"],"prefix":"10.1016","volume":"142","author":[{"given":"Briony","family":"Larance","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natacha","family":"Carragher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.","family":"Mattick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Lintzeris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Degenhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1524-4733.2007.00214.x","article-title":"Classifying patients by antipsychotic adherence patterns using latent class analysis: characteristics of nonadherent groups in the California Medicaid (Medi-Cal) Program","volume":"11","author":"Ahn","year":"2008","journal-title":"Value Health"},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0010","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification","volume":"19","author":"Akaike","year":"1974","journal-title":"IEEE T. Automat. Control"},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jsat.2005.02.007","article-title":"An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research","volume":"28","author":"Amato","year":"2005","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0020","series-title":"Clinical Guidelines: Assessing Suitability for Unsupervised Medication Doses in the Treatment of Opioid Dependency","author":"Australasian Chapter of Addiction Medicine","year":"2006"},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0025","series-title":"National Opioid Pharmacotherapy Statistics Annual Data collection: 2007 Report","author":"Australian Institute of Health Welfare","year":"2008"},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0030","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drugalcdep.2008.02.012","article-title":"Optimising the benefits of unobserved dose administration for stable opioid maintenance patients: follow-up of a randomised trial","volume":"96","author":"Bell","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0035","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/j.1360-0443.2007.01979.x","article-title":"A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine\u2013naloxone for heroin dependence","volume":"102","author":"Bell","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0040","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jad.2008.05.015","article-title":"Subtypes of depression in a nationally representative sample","volume":"113","author":"Carragher","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.psychres.2010.12.022","article-title":"A latent class analysis of DSM-IV criteria for pathological gambling: Results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"187","author":"Carragher","year":"2011","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0050","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/aje\/kwg049","article-title":"Developmental typology of trajectories to nighttime bladder control: epidemiologic application of longitudinal latent class analysis","volume":"157","author":"Croudace","year":"2003","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0055","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0376-8716(98)00028-3","article-title":"Self-report among injecting drug users: a review","volume":"51","author":"Darke","year":"1998","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0060","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.addbeh.2011.01.004","article-title":"Consumer and treatment provider perspectives on reducing barriers to opioid substitution treatment and improving treatment attractiveness","volume":"36","author":"Deering","year":"2011","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0065","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","article-title":"Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies","volume":"106","author":"Degenhardt","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0070","author":"Degenhardt","year":"2008"},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0075","series-title":"National Pharmacotherapy Policy for People Dependent on Opioids","author":"Department of Health and Ageing","year":"2007"},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0080","series-title":"Policy for Maintainance Pharmacotherapy for Opioid Dependence. Drugs Policy and Services Branch","author":"Drugs and Poisons Regulation Group","year":"2006"},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0260","unstructured":"Drugs of Dependence Unit, 2006. Policy relating to the use of Suboxone (buprenorphine and naloxone) and Subutex (buprenorphine) in opioid dependence treatment programs. Drug and Alcohol Services South Australia, Government of South Australia."},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0085","series-title":"Policy for Non-supervised Dosing of Methadone and Buprenorphine in Opioid Dependence Treatment Programs","author":"Drugs of Dependence Unit","year":"2007"},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0090","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0197-2456(84)90012-6","article-title":"Adherence measures and their utility","volume":"5","author":"Dunbar","year":"1984","journal-title":"Control Clin. Trials"},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0095","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pnpbp.2010.12.002","article-title":"Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance","volume":"35","author":"Gerra","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0100","first-page":"CD004145","article-title":"Oral substitution treatment of injecting drug users for prevention of HIV infection","volume":"10","author":"Gowing","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0105","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.addbeh.2010.01.001","article-title":"Unobserved versus office buprenorphine\/naloxone induction: a pilot randomised clinical trial","volume":"35","author":"Gunderson","year":"2010","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0110","series-title":"Methadone Maintenance Treatment as a Crime Control Measure, Crime and Justice Bulletin No. 29","author":"Hall","year":"1996"},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0115","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1345\/aph.1L496","article-title":"Comparison of methods to assess medication adherence and classify nonadherence","volume":"43","author":"Hansen","year":"2009","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jsat.2007.08.013","article-title":"Patterns of adherence to oral methadone: implications for prescribers","volume":"35","author":"Haskew","year":"2008","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0125","first-page":"CD000011","article-title":"Interventions for enhancing medication adherence","author":"Haynes","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0250","doi-asserted-by":"crossref","unstructured":"Henry-Edwards, S., Gowing, L., White, J., Ali, R., Bell, J., Brough, R., Lintzeris, N., Ritter, A., Quigley, A., 2003. Clinical guidelines and procedures for the use of methadone in the maintenance treatment of opioids dependence. Australian Government Department of Health and Ageing, Commonwealth of Australia.","DOI":"10.1037\/e677012010-001"},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.pra.0000344917.43780.77","article-title":"Medication adherence: a review of the literature and implications for clinical practice","volume":"15","author":"Julius","year":"2009","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0135","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.drugalcdep.2011.04.002","article-title":"Post-marketing surveillance of buprenorphine\u2013naloxone in Australia: diversion, injection and adherence with supervised dosing","volume":"118","author":"Larance","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0140","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1465-3362.2010.00283.x","article-title":"Definitions related to the use of pharmaceutical opioids: extramedical use, diversion, non-adherence and aberrant medication-related behaviours","volume":"30","author":"Larance","year":"2011","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0145","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1465-3362.2010.00274.x","article-title":"Prescribers\u2019 perceptions of the diversion and injection of medication by opioid substitution treatment patients","volume":"30","author":"Larance","year":"2011","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0255","unstructured":"Lintzeris, N., Clark, N., Winstock, A., Dunlop, A., Gowing, L., Ritter, A., Bell, J., Quigley, A.J., Mattick, R.P., Monheit, B., White, J., 2006. National clinical guidelines and procedures for the use of buprenorphine in the maintenance treatment of opoid dependence. Australian Government National Drug Strategy, Commonwealth of Australia."},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0150","series-title":"Investigation of Methadone Dosing in Victoria: Factors Influencing Dosing Levels","author":"Lintzeris","year":"2007"},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0155","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/biomet\/88.3.767","article-title":"Testing the number of components in a normal mixture","volume":"88","author":"Lo","year":"2001","journal-title":"Biometrika"},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0160","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/09595230801935706","article-title":"Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment","volume":"27","author":"Madden","year":"2008","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0165","first-page":"CD002209","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"2","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0170","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2008","author":"Mattick","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0175","series-title":"Latent Class Analysis","author":"McCutcheon","year":"1987"},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0180","series-title":"New South Wales Opioid Treatment Program: Clinical Guidelines for Methadone and Buprenorphine Treatment of Opioid Dependence","author":"Mental Health and Drug and Alcohol Office","year":"2006"},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0185","series-title":"Mplus User's Guide (1998\u20132007)","author":"Muthen","year":"2007"},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0190","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/10705510701575396","article-title":"Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo simulation study","volume":"14","author":"Nylund","year":"2007","journal-title":"Struct. Equ. Model."},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0195","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3390\/medicina43030029","article-title":"Outpatient methadone maintenance treatment program. Quality of life and health of opioid-dependent persons in Lithuania","volume":"43","author":"Padaiga","year":"2007","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0200","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1287\/mksc.12.1.103","article-title":"An empirical pooling approach for estimating marketing mix elasticities with PIMS data","volume":"12","author":"Ramaswamy","year":"1993","journal-title":"Market. Sci."},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0205","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/09595230500263939","article-title":"The relationship between take-away methadone policies and methadone diversion","volume":"24","author":"Ritter","year":"2005","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0210","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1214\/aos\/1176344136","article-title":"Estimating the dimension of a model","volume":"6","author":"Schwartz","year":"1978","journal-title":"Ann. Statist."},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0215","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF02294360","article-title":"Application of model-selection criteria to some problems in multivariate analysis","volume":"52","author":"Sclove","year":"1987","journal-title":"Psychometrika"},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0220","doi-asserted-by":"crossref","first-page":"c4851","DOI":"10.1136\/bmj.c4851","article-title":"Impact of supervision of methadone consumption on deaths related to methadone overdose (1993\u20132008): analyses using OD4 index in England and Scotland","volume":"341","author":"Strang","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0225","series-title":"Methadone Maintenance Treatment and Other Opioid Replacement Therapies","author":"Ward","year":"1998"},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0230","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3109\/10826080903080664","article-title":"Diversion and injection of methadone and buprenorphine among clients in public opioid treatment clinics in New South Wales, Australia","volume":"45","author":"Winstock","year":"2010","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0235","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/09687630701425865","article-title":"Knowledge about buprenorphine and methadone among those receiving treatment for opioid dependence","volume":"15","author":"Winstock","year":"2008","journal-title":"Drugs Educ. Prev. Pol."},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0240","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.drugpo.2007.03.002","article-title":"Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia","volume":"19","author":"Winstock","year":"2008","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2014.05.018_bib0245","series-title":"Guidelines For The Psychosocially Assisted Pharmacological Treatment Of Opioid Dependence","author":"World Health Organization","year":"2009"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871614009004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871614009004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T06:15:16Z","timestamp":1565504116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871614009004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":52,"alternative-id":["S0376871614009004"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.05.018","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A latent class analysis of self-reported clinical indicators of psychosocial stability and adherence among opioid substitution therapy patients: Do stable patients receive more unsupervised doses?","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}